Recent Analyst Forecasts and Stock Ratings
Contineum Therapeutics Inc. FAQ's
Contineum Therapeutics Inc. has been rated by research analysts at Morgan Stanley, Robert W. Baird, RBC Capital, Leerink Partners, Stifel Nicolaus in the past 90 days.
Contineum Therapeutics Inc. has been rated by research analysts at Morgan Stanley, Robert W. Baird, RBC Capital, Leerink Partners, Stifel Nicolaus in the past 90 days.